ATRA icon

Atara Biotherapeutics

86 hedge funds and large institutions have $519M invested in Atara Biotherapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 10 closing their positions.

Holders
86
Holders Change
+4
Holders Change %
+4.88%
% of All Funds
1.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
29
Reduced
24
Closed
10
Calls
$750K
Puts
$2.85M
Net Calls
-$2.1M
Net Calls Change
-$2.55M
Name Market Value Shares Shares
Change
Shares
Change %
Envestnet Asset Management
76
Envestnet Asset Management
Illinois
$18K 40 -18 -31%
SPIA
77
Steward Partners Investment Advisory
New York
$18K 40 +40 New
CG
78
Cutler Group
California
$9K 20 -84 -81%
AG
79
Advisor Group
Arizona
$8K 16 +6 +60%
CHP
80
Cable Hill Partners
Oregon
$7K 16
Citigroup
81
Citigroup
New York
$4K 9 +6 +200%
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$2K 5 -86 -95%
GWM
83
Geneos Wealth Management
Colorado
$2K 6
TDC
84
Thompson Davis & Co
Virginia
$2K 5 +5 New
LTFS
85
Ladenburg Thalmann Financial Services
Florida
$1K 2
PA
86
Perceptive Advisors
New York
-1,404 Closed
EIM
87
Essex Investment Management
Massachusetts
-1,036 Closed
Millennium Management
88
Millennium Management
New York
-869 Closed
NFA
89
Nationwide Fund Advisors
Ohio
-539 Closed
PCM
90
Prelude Capital Management
New York
-529 Closed
Russell Investments Group
91
Russell Investments Group
United Kingdom
-410 Closed
SG Americas Securities
92
SG Americas Securities
New York
-342 Closed
TRCT
93
Tower Research Capital (TRC)
New York
-50 Closed
Simplex Trading
94
Simplex Trading
Illinois
-13 Closed
KF
95
Krilogy Financial
Missouri
-8 Closed
ACP
96
Acuta Capital Partners
California
Susquehanna International Group
97
Susquehanna International Group
Pennsylvania
IA
98
IFP Advisors
Florida
PNC Financial Services Group
99
PNC Financial Services Group
Pennsylvania
$0 1 +1 New